Product: Loxapine Capsules, USP  50 mg, Rx Only,  100-count bottles, NDC 0378-7050-01
Reason for recall: CGMP Deviations
Recall initiated: 20180424
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated